-+ 0.00%
-+ 0.00%
-+ 0.00%

Minerva Neurosciences Q2 EPS $(0.43) Beats $(0.90) Estimate

Benzinga·08/14/2025 20:37:00
Listen to the news
Minerva Neurosciences (NASDAQ:NERV) reported quarterly losses of $(0.43) per share which beat the analyst consensus estimate of $(0.90) by 52.22 percent. This is a 60.55 percent increase over losses of $(1.09) per share from the same period last year.